Mylan-lamotrigine - 150 Mg
Mylan-Lamotrigine 150 mg Recall Mylan-Lamotrigine 150 mg tablets are being recalled across Canada due to a product quality and safety issue. This recall affects all patients who have this medication. The specific quality concern has been identified as a Class I recall, which is the most serious classification.
- Reason
- Product quality - Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2013-06-06
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0c936046-e666-4dfd-9691-84914ed54c81